Related Experiment Video
Updated: Jul 8, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Oxidative stress and the JNK pathway in diabetes
Hideaki Kaneto1, Taka-aki Matsuoka, Yoshihisa Nakatani
1Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. kaneto@medone.med
Abstract:
Under diabetic conditions, oxidative stress is induced and the JNK pathway is activated, which is involved in deterioration of pancreatic beta-cell function found in diabetes. Oxidative stress and/or activation of the JNK pathway suppress insulin gene expression, accompanied by reduction of PDX-1 DNA binding activity. Treatment with antioxidants and/or suppression of the JNK pathway protect beta-cells from some of the toxic effects of hyperglycemia. The JNK pathway is also involved in the progression of insulin resistance; suppression of the JNK pathway in obese diabetic mice markedly improves insulin resistance and ameliorates glucose tolerance. The phosphorylation state of key molecules for insulin signaling is altered upon modification of the JNK pathway. Taken together, the JNK pathway plays a crucial role in progression of insulin resistance as well as beta-cell dysfunction found in diabetes and thus could be a potential therapeutic target for diabetes.
Insights
The JNK pathway, activated by oxidative stress in diabetes, impairs pancreatic beta-cell function and insulin resistance. Suppressing this pathway may offer a therapeutic target for diabetes treatment.
Area of Science:
- Diabetes research
- Cellular signaling pathways
- Metabolic disorders
Background:
- Diabetic conditions induce oxidative stress and activate the JNK pathway, contributing to pancreatic beta-cell dysfunction.
- Oxidative stress and JNK pathway activation suppress insulin gene expression and reduce PDX-1 DNA binding activity.
- Hyperglycemia's toxic effects on beta-cells can be mitigated by antioxidants or JNK pathway suppression.
Purpose of the Study:
- To investigate the role of the JNK pathway in beta-cell dysfunction and insulin resistance in diabetes.
- To explore the therapeutic potential of targeting the JNK pathway for diabetes treatment.
Main Methods:
- Examined the effects of oxidative stress and JNK pathway activation on insulin gene expression and PDX-1 DNA binding activity.
- Investigated the impact of JNK pathway suppression on insulin resistance and glucose tolerance in obese diabetic mice.
- Analyzed alterations in key insulin signaling molecules due to JNK pathway modification.
Main Results:
- JNK pathway activation is linked to the deterioration of pancreatic beta-cell function and suppressed insulin gene expression.
- Suppression of the JNK pathway protects beta-cells from hyperglycemia's toxic effects.
- In obese diabetic mice, JNK pathway suppression improved insulin resistance and glucose tolerance.
- JNK pathway modification altered the phosphorylation state of key insulin signaling molecules.
Conclusions:
- The JNK pathway is critically involved in the progression of insulin resistance.
- The JNK pathway plays a crucial role in beta-cell dysfunction observed in diabetes.
- Targeting the JNK pathway presents a potential therapeutic strategy for managing diabetes.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Psychoneuroimmunology: Diabetes and Cancer
Type II Diabetes I: Introduction
Diabetic Ketoacidosis ll: Pathophysiology